Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Eastman Chemical Company (EMN)

NYSE: EMN · Plastic Materials, Synth Resins & Nonvulcan Elastomers · Kingsport, TN

Our rating: Neutral

Neutral reaffirmed at $66.78, moderate conviction, November 2, 2026.

Breaks if: The Neutral call turns Positive if Eastman reports year-on-year revenue growth of at least 3% for two consecutive quarterly filings and net margin recovers above 7% within those same four quarters — both conditions together would signal a genuine demand-cycle turn rather than a one-quarter noise event. It turns Cautious if revenue decline accelerates beyond -10% on a year-on-year basis in any single quarterly filing, or if net margin falls below 3% for two consecutive quarters — at that point the 16x earnings multiple would be pricing in a recovery the reported numbers no longer support.

Key figures

Market value$6.7B
Revenue, last 12 months$9.0B
Net income, last 12 months$625M
Free cash flow, last 12 months$469M
Price to earnings10.8×
Free cash flow yield7.0%
Dividend yield5.7%
Operating marginn/a
Return on equity10.4%
Beta to the S&P 5001.04
Volatility, annualized34.1%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$2.4B8.3%$2.19$195M
June 30, 2026$2.5B9.9%$1.59$124M
March 31, 2026$2.2B−4.9%$0.93−$240M
December 31, 2025$2.0B−12.1%$0.72$390M
September 30, 2025$2.2B−10.6%$0.60$265M
June 30, 2025$2.3B−3.2%$1.20$83M
March 31, 2025$2.3B−0.9%$1.57−$314M
December 31, 2024$2.2B1.7%$2.81$361M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

9 ledger entries and 37 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.